170 related articles for article (PubMed ID: 18535474)
21. Functionally active macrophage-derived myeloperoxidase in the skin of drug-induced toxic epidermal necrolysis.
Paquet P; De Groote D; Piérard GE
Dermatology; 2010; 220(3):201-7. PubMed ID: 20332596
[TBL] [Abstract][Full Text] [Related]
22. Fatal toxic epidermal necrolysis induced by carbamazepine treatment in a patient who previously had carbamazepine-induced Stevens-Johnson syndrome.
Huang LY; Liao WC; Chiou CC; Lou JP; Hu P; Ko FC
J Formos Med Assoc; 2007 Dec; 106(12):1032-7. PubMed ID: 18194909
[TBL] [Abstract][Full Text] [Related]
23. Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis.
de Araujo E; Dessirier V; Laprée G; Valeyrie-Allanore L; Ortonne N; Stathopoulos EN; Bagot M; Bensussan A; Mockenhaupt M; Roujeau JC; Tsapis A
Exp Dermatol; 2011 Feb; 20(2):107-12. PubMed ID: 21255088
[TBL] [Abstract][Full Text] [Related]
24. Toxic epidermal necrolysis in patient with malignant astrocytoma.
Kaczmarska-Turek D; Bartnik P; Kacperczyk J; Orlewski J; Olszewska M; Krasnodębska-Kiljańska M
Pol Merkur Lekarski; 2016 Jan; 40(235):25-7. PubMed ID: 26891432
[TBL] [Abstract][Full Text] [Related]
25. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
McCullough M; Burg M; Lin E; Peng D; Garner W
Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
[TBL] [Abstract][Full Text] [Related]
26. Anticonvulsant-induced toxic epidermal necrolysis: monitoring the immunologic response.
Leyva L; Torres MJ; Posadas S; Blanca M; Besso G; O'Valle F; del Moral RG; Santamaría LF; Juárez C
J Allergy Clin Immunol; 2000 Jan; 105(1 Pt 1):157-65. PubMed ID: 10629466
[TBL] [Abstract][Full Text] [Related]
27. [Changes in contents of Zn, Cu, Fe, Ca, Mg in serum, urine and blister fluid after burn injury].
Guo Z; Li L; Zhao L
Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1997 May; 13(3):195-8. PubMed ID: 10451999
[TBL] [Abstract][Full Text] [Related]
28. The biochemistry of blister fluid from pediatric burn injuries: proteomics and metabolomics aspects.
Zang T; Broszczak DA; Broadbent JA; Cuttle L; Lu H; Parker TJ
Expert Rev Proteomics; 2016; 13(1):35-53. PubMed ID: 26581649
[TBL] [Abstract][Full Text] [Related]
29. Possible involvement of gelatinase A (MMP2) and gelatinase B (MMP9) in toxic epidermal necrolysis or Stevens-Johnson syndrome.
Gaultier F; Ejeil AL; Igondjo-Tchen S; Dohan D; Dridi SM; Maman L; Wierzba CB; Stania D; Pellat B; Lafont A; Godeau G; Gogly B
Arch Dermatol Res; 2004 Oct; 296(5):220-5. PubMed ID: 15449075
[TBL] [Abstract][Full Text] [Related]
30. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.
Mockenhaupt M; Messenheimer J; Tennis P; Schlingmann J
Neurology; 2005 Apr; 64(7):1134-8. PubMed ID: 15824335
[TBL] [Abstract][Full Text] [Related]
31. Use of intravenous immunoglobulin for Stevens-Johnson syndrome and toxic epidermal necrolysis in children: Report of two cases secondary to anticonvulsants.
Romero-Tapia SJ; Cámara-Combaluzier HH; Baeza-Bacab MA; Cerino-Javier R; Bulnes-Mendizabal DP; Virgen-Ortega C
Allergol Immunopathol (Madr); 2015; 43(2):227-9. PubMed ID: 25183634
[No Abstract] [Full Text] [Related]
32. Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand.
Rattanavipapong W; Koopitakkajorn T; Praditsitthikorn N; Mahasirimongkol S; Teerawattananon Y
Epilepsia; 2013 Sep; 54(9):1628-38. PubMed ID: 23895569
[TBL] [Abstract][Full Text] [Related]
33. Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a university hospital.
Ferrándiz-Pulido C; García-Fernández D; Domínguez-Sampedro P; García-Patos V
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1153-9. PubMed ID: 21198948
[TBL] [Abstract][Full Text] [Related]
34. Gelatinases in drug-induced toxic epidermal necrolysis.
Paquet P; Nusgens BV; Piérard GE; Lapière CM
Eur J Clin Invest; 1998 Jul; 28(7):528-32. PubMed ID: 9726031
[TBL] [Abstract][Full Text] [Related]
35. Early protein alteration in blister fluid and serum associated with burn injury.
Deitch EA; Emmett M
J Trauma; 1986 Jan; 26(1):34-9. PubMed ID: 3941429
[TBL] [Abstract][Full Text] [Related]
36. Prostaglandins released into human burn blister fluid.
Sugiyama S; Norimatsu I; Kobayashi M; Ozawa T; Aoyama H; Suzuki K; Izawa Y
Biomedicine; 1978 Apr; 29(2):51-3. PubMed ID: 667287
[TBL] [Abstract][Full Text] [Related]
37. Recurrent blisters in a case of resolving Stevens-Johnson syndrome/toxic epidermal necrolysis.
Chuang YN; Ho YY; Chiu TM
Indian J Dermatol Venereol Leprol; 2014; 80(6):546-7. PubMed ID: 25382518
[No Abstract] [Full Text] [Related]
38. Management of toxic epidermal necrolysis in a 15-year-old girl.
Clennett S; Hosking G
J Wound Care; 2003 Apr; 12(4):151-4. PubMed ID: 12715488
[TBL] [Abstract][Full Text] [Related]
39. Stevens-Johnson syndrome/toxic epidermal necrolysis mouse model generated by using PBMCs and the skin of patients.
Saito N; Yoshioka N; Abe R; Qiao H; Fujita Y; Hoshina D; Suto A; Kase S; Kitaichi N; Ozaki M; Shimizu H
J Allergy Clin Immunol; 2013 Feb; 131(2):434-41.e1-9. PubMed ID: 23111236
[TBL] [Abstract][Full Text] [Related]
40. Oxcarbazepine-induced Stevens-Johnson syndrome: a case report.
Lin LC; Lai PC; Yang SF; Yang RC
Kaohsiung J Med Sci; 2009 Feb; 25(2):82-6. PubMed ID: 19321411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
